Related Experiment Videos
Executive dysfunction and apathy predict functional impairment in Alzheimer disease
Patricia A Boyle1, Paul F Malloy, Stephen Salloway
1Brown Medical School, Providence, RI, USA. boyle@bu.edu.
Summary
Executive cognitive dysfunction and apathy significantly impact daily functioning in Alzheimer disease (AD) patients. These symptoms are linked to difficulties with both basic and instrumental activities of daily living.
Area of Science:
- Neurology
- Gerontology
- Psychology
Background:
- Alzheimer disease (AD) is a progressive neurodegenerative disorder.
- Functional impairment significantly affects the quality of life for individuals with AD.
- Understanding the relationship between cognitive/behavioral symptoms and functional decline is crucial for patient care.
Purpose of the Study:
- To investigate the association between executive cognitive dysfunction and frontally-mediated behavioral disturbances with functional impairment in mild-to-moderate Alzheimer disease (AD).
Main Methods:
- Forty-five patients with AD were assessed using the Mattis Dementia Rating Scale.
- Caregivers completed the Frontal Systems Behavioral Inventory and a modified Activities of Daily Living (ADLs) Questionnaire.
- Multiple regression analyses were employed to determine the variance explained by cognitive and behavioral factors.
Main Results:
- Executive cognitive dysfunction and apathy explained 44% of the variance in instrumental ADLs.
- Executive dysfunction alone accounted for 17% of instrumental ADL variance, with apathy contributing an additional 27%.
- Executive dysfunction and frontal-behavioral impairment explained 28% of basic ADL (BADL) variance, with apathy uniquely contributing after controlling for executive dysfunction.
Conclusions:
- Specific cognitive deficits, particularly executive dysfunction, and behavioral symptoms like apathy are significantly associated with functional impairment in Alzheimer disease.
- These findings highlight the importance of addressing both cognitive and behavioral aspects in managing functional decline in AD patients.